MA MPJE 2024 Key Revision Questions and Correct Answers

Massachusetts State Board of Pharmacy consists of how many members? A) 7 B) 13 C) 9 D) 5 - (b) 13, [M.G.L Chapter 13: Section 22]. The governor shall appoint 13 members to the board. Members shall be residents of the commonwealth. No person who has been convicted of a felony or other crime involving embezzlement, theft, fraud or perjury shall serve as a member of the board. The board shall be comprised of: 8 registered pharmacists; 1 pharmacy technician; 1 representative of the public with experience in health care service delivery, administration or consumer advocacy, 1 physician registered; 1 nurse registered; and 1 expert in patient safety and quality improvement. (b). The 8 registered pharmacists of the board shall each have had at least 7 consecutive years of experience in the practice of pharmacy and shall be currently employed in the practice of pharmacy in the commonwealth at the time of appointment or reappointment. (c). 2 of the 8 registered pharmacist members shall be independent pharmacists employed in the independent pharmacy setting. (d). 2 of the 8 registered pharmacist members shall be chain pharmacists employed in the chain pharmacy setting. (e). 1 of the 8 registered pharmacist members shall have had at least 7 years of experience in a hospital setting within the commonwealth. (f). 1 of the 8 registered pharmacist members shall have had at least 7 years of experience being employed in a long-term care pharmacy setting. (g). 1 of the 8 registered pharmacist members shall have had at least 7 years of experience in the practice of sterile compounding and shall be engaged in sterile compounding as a routine function of the member's employment. (h). 1 of the 8 registered pharmacist members shall be employed in an academic or scholarly position related to the practice of pharmacy with an institution of higher learning licensed by the commonwealth. (j). the pharmacy technician membe According to Massachusetts Pharmacy Law, a written prescription for a controlled substance in Schedule II shall become invalid SIX months after the date of issuance. A) True B) False - (b) False, [Massachusetts Controlled Substance Act Chapter 94C: Section 23(a)]. According to Massachusetts Pharmacy Law, a written prescription for a controlled substance in Schedule II shall become invalid THIRTY DAYS (30) after the date of issuance. A written prescription for a controlled substance in Schedule II shall not be refilled and shall be kept in a separate file. The pharmacist filling a written prescription for a controlled substance in Schedule II shall endorse his own signature on the face thereof. Which of the following information IS/ARE TRUE about voluntary non-opiate directive form? I. The form shall indicate to all practitioners that an individual shall not be administered or offered a prescription or medication order for an opiate. II. An individual may execute and file a voluntary non-opiate directive form with a registered practitioner or other authority authorized by the secretary to accept the voluntary non-opiate directive form for filing. III. An individual may revoke the voluntary non-opiate directive form for any reason and may do so by written or oral means. A) I only B) I and II only C) II and III only D) All of the above - (d) All, [Massachusetts Controlled Substance Act Chapter 94C: Section 18B]. (a). The department shall establish a voluntary non-opiate directive form. The form shall indicate to all practitioners that an individual shall not be administered or offered a prescription or medication order for an opiate. The form shall be posted on the department's searchable website. An individual may execute and file a voluntary non-opiate directive form with a registered practitioner or other authority authorized by the secretary to accept the voluntary non-opiate directive form for filing. An individual may revoke the voluntary non-opiate directive form for any reason and may do so by written or oral means. A written prescription that is presented at an outpatient pharmacy or a prescription that is electronically transmitted to an outpatient pharmacy shall be presumed to be valid for the purposes of this section and a pharmacist in an outpatient setting shall not be held in violation of this section for dispensing a controlled substance in contradiction to a voluntary non-opiate directive form, except upon evidence that the pharmacist acted knowingly against the voluntary non-opiate directive form. Any board of professional licensure may limit, condition or suspend the license of or assess fines against a licensed health care provider who recklessly or negligently fails to comply with a person's voluntary non-opiate directive form. In order for a pharmacist to enter into a collaborative practice agreement, the pharmacist shall: I. hold a current license to practice pharmacy in the commonwealth and currently be engaged in pharmacy practice in the commonwealth. II. have earned a doctor of pharmacy degree or have completed 5 years of experience as a licensed pharmacist or the equivalent. III. have at least $250,000 of professional liability insurance. A) I only B) I and II only C) II and III only D) All of the above - (b) I and II are true, [M.G.L Chapter 112: Section 24B1/2(b) and 247 CMR 16.04(3)]. Collaborative drug therapy management may include: a. collecting and reviewing patient histories;